Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 2 3Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 3Other hematologic neoplasm 2Genitourinary 2CNS 2Breast 2Thoracic 1Plasma cell 1Other solid neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 778Fluorouracil 637Capecitabine 573Gemcitabine 478Leucovorin 458Irinotecan 444Bevacizumab 443Cisplatin 337Radiotherapy 282Cetuximab 251Paclitaxel 180S 1 (combination) 175pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 130apatinib 130130-nm albumin-bound paclitaxel 127Folfox protocol 120durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106Surgical Procedures, Operative 102regorafenib 101Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Practice Guidelines as Topic × Gastrointestinal × Clear all
NCT03844620 2026-01-09

Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03745794 2025-12-23

Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery

M.D. Anderson Cancer Center

Phase 2 Completed
136 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT04205955 2024-05-01

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

SWOG Cancer Research Network

Phase 2 Completed
95 enrolled 30 charts
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡